{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:24:47Z","timestamp":1784330687636,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.jfo.2017.04.007","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T02:01:44Z","timestamp":1505268104000},"page":"681-695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Scl\u00e9rites et \u00e9piscl\u00e9rites"],"prefix":"10.1016","volume":"40","author":[{"given":"E.","family":"H\u00e9ron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Bourcier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2017.04.007_bib0185","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/S0161-6420(99)00719-8","article-title":"Scleritis: a clinicopathologic study of 55\u00a0cases","volume":"106","author":"Riono","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2017.04.007_bib0190","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1136\/bjo.2007.126425","article-title":"Immunopathology of necrotizing scleritis","volume":"92","author":"Usui","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.04.007_bib0195","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.preteyeres.2013.02.004","article-title":"Scleritis: immunopathogenesis and molecular basis for therapy","volume":"35","author":"Wakefield","year":"2013","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jfo.2017.04.007_bib0200","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/bjo.60.3.163","article-title":"Scleritis and episcleritis","volume":"60","author":"Watson","year":"1976","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.04.007_bib0205","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0002-9394(00)00710-8","article-title":"Episcleritis and scleritis: clinical features and treatment results","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.04.007_bib0210","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ophtha.2011.07.013","article-title":"Clinical characteristics of a large cohort of patients with scleritis and episcleritis","volume":"119","author":"Sainz de la Maza","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2017.04.007_bib0215","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1016\/S0161-6420(99)90543-2","article-title":"Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients","volume":"106","author":"McCluskey","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2017.04.007_bib0220","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ophtha.2003.06.006","article-title":"Evaluation of patients with scleritis for systemic disease","volume":"111","author":"Akpek","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2017.04.007_bib0225","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ajo.2007.09.024","article-title":"Immunologic markers as potential predictors of systemic autoimmune disease in patients with idiopathic scleritis","volume":"145","author":"Lin","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.04.007_bib0230","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.ajo.2009.07.021","article-title":"Scleritis disease association in a community-based referral practice","volume":"148","author":"Raji","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.04.007_bib0235","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/ICO.0b013e3181ac9fad","article-title":"Clinical features, prognosis, and treatment results of patients with scleritis from 2\u00a0tertiary eye care centers in Turkey","volume":"29","author":"Erkanli","year":"2010","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2017.04.007_bib0240","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ophtha.2012.08.005","article-title":"Visual outcome, treatment results, and prognostic factors in patients with scleritis","volume":"120","author":"Wieringa","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2017.04.007_bib0245","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.revmed.2013.09.013","article-title":"Scl\u00e9rites, aspects cliniques, \u00e9tiologiques et th\u00e9rapeutiques\u00a0: \u00e0 propos d\u2019une s\u00e9rie de 32\u00a0observations","volume":"35","author":"Leal","year":"2014","journal-title":"Rev Med Int"},{"key":"10.1016\/j.jfo.2017.04.007_bib0250","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0161-6420(91)32269-3","article-title":"Progression of scleral disease","volume":"98","author":"Tuft","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2017.04.007_bib0255","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.ophtha.2003.12.052","article-title":"Adverse ocular drug reactions recently identified by the national registry of drug-induced ocular side effects","volume":"111","author":"Fraunfelder","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2017.04.007_bib0260","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/bjo.76.1.17","article-title":"Surgically induced necrotising sclerokeratitis (SINS), precipitating factors and response to treatment","volume":"76","author":"O\u2019Donoghue","year":"1992","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.04.007_bib0265","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/S0161-6420(91)32062-1","article-title":"Necrotizing scleritis after ocular surgery. A clinicopathologic study","volume":"98","author":"Sainz de la Maza","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2017.04.007_bib0270","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/ICO.0000000000000174","article-title":"Infectious scl\u00e9ritis in Taiwan \u2013 a 10-year review in a tertiary-care hospital","volume":"33","author":"Ho","year":"2014","journal-title":"Cornea"},{"key":"10.1016\/j.jfo.2017.04.007_bib0275","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.ophtha.2012.01.033","article-title":"Clinical features and presentation of infectious scleritis from herpes viruses: a report of 35\u00a0cases","volume":"119","author":"Gonzalez-Gonzalez","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2017.04.007_bib0280","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ajo.2009.06.025","article-title":"Chronic herpes simplex scleritis: characterization of 9\u00a0cases of an underrecognized clinical entity","volume":"148","author":"Bhat","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.04.007_bib0285","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.semarthrit.2012.08.003","article-title":"Ophthalmologic manifestations of systemic necrotizing vasculitides at diagnosis: a retrospective study of 1286\u00a0patients and a review of the literature","volume":"42","author":"Rothschild","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jfo.2017.04.007_bib0290","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ajo.2009.09.018","article-title":"HLA typing: use and misuse","volume":"149","author":"Zamecki","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.04.007_bib0295","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/ICU.0b013e32834bdfe2","article-title":"Ocular manifestations of systemic disease: antineutrophil cytoplasmic antibody-associated vasculitis","volume":"22","author":"Schmidt","year":"2011","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jfo.2017.04.007_bib0300","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.survophthal.2011.05.003","article-title":"Systemic therapy with conventional and novel immunomodulatory agents for ocular inflammatory disease","volume":"56","author":"Durrani","year":"2011","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jfo.2017.04.007_bib0305","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ophtha.2011.07.043","article-title":"Scleritis therapy","volume":"119","author":"Sainz de la Maza","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2017.04.007_bib0310","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.ophtha.2009.04.020","article-title":"Methotrexate for ocular inflammatory diseases","volume":"116","author":"Gangaputra","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2017.04.007_bib0315","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ajo.2009.05.008","article-title":"Azathioprine for ocular inflammatory diseases","volume":"148","author":"Pasadhika","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.04.007_bib0320","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2009.08.010","article-title":"Cyclosporine for ocular inflammatory diseases","volume":"117","author":"Ka\u00e7maz","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2017.04.007_bib0325","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ophtha.2009.06.060","article-title":"Cyclosphosphamide for ocular inflammatory diseases","volume":"117","author":"Pujari","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2017.04.007_bib0330","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ajo.2009.09.026","article-title":"Mycophenolate mofetil for ocular inflammation","volume":"149","author":"Daniel","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.04.007_bib0335","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.ophtha.2008.04.026","article-title":"Comparison of antimetabolite drugs as corticosteroid-sparing therapy for non-infectious ocular inflammation","volume":"115","author":"Galor","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2017.04.007_bib0340","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/bjo.2008.150961","article-title":"Infliximab for the treatment of refractory scleritis","volume":"94","author":"Doctor","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.04.007_bib0345","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/bjo.2007.133173","article-title":"Rituximab for treatment of ocular inflammatory disease: a series of four cases","volume":"93","author":"Kurz","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.04.007_bib0350","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.ophtha.2011.02.043","article-title":"Long-term, multi-center evaluation of subconjonctival injection of triamcinolone for non-necrotizing, non-infectious anterior scleritis","volume":"118","author":"Sohn","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2017.04.007_bib0355","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3899\/jrheum.110865","article-title":"Scleritis: a paradoxical effect of etanercept? Etanercept-associated inflammatory eye disesase","volume":"39","author":"Gaujoux-Viala","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jfo.2017.04.007_bib0360","first-page":"1","article-title":"Scl\u00e9rites et \u00e9piscl\u00e9rites","volume":"14","author":"H\u00e9ron","year":"2017","journal-title":"EMC Ophtalmol"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551217302607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551217302607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:07:12Z","timestamp":1759259232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551217302607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0181551217302607"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2017.04.007","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scl\u00e9rites et \u00e9piscl\u00e9rites","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2017.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}